CMS issues Stage 2 guidance

New guidance from the Centers for Medicare & Medicaid Services addresses Meaningful Use Stage 2 requirements related to summary of care, clinical summary and patient electronic access to their records.

The four-page guidance sheet aims to aid eligible professionals by outlining the required data elements and provides additional guidance, according to CMS. “While some of the data elements are common between these three objectives, other data elements are individual to each objective.”

The guidance details specific information requirements for each measure, includes reminders of timelines and notes when information does not have to be shared.

Access the guidance is available here.

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year.